Pharmacokinetics of cefepime administered by i.v. and i.m. routes to ewes

被引:19
作者
Ismail, M [1 ]
机构
[1] Cairo Univ, Fac Vet Med, Dept Pharmacol, Giza 12211, Egypt
关键词
D O I
10.1111/j.1365-2885.2005.00689.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics of cefepime were studied following i.v. and i.m. administration of 20 mg/kg in 10 ewes. Following i.v. administration of a single dose, the plasma concentration-time curves of cefepime were best fitted using a two-compartment open model. The elimination half-life (t(1/2 beta)) was 1.76 +/- 0.07 h, volume of distribution at steady-state [V-d(ss)] was 0.32 +/- 0.01 L/kg and total body clearance (Cl-B) was 2.37 +/- 0.05 mL/min.kg. Following i.m. administration, the drug was rapidly absorbed with an absorption half-life (t(1/2ab)) of 0.49 +/- 0.05 h, maximum plasma concentration (C-max) of 31.9 +/- 1.5 mu g/mL was attained at (t(max)) 1.1 +/- 0.2 h and the drug was eliminated with an elimination half-life (t(1/2el)) of 2.06 +/- 0.11 h. The systemic bioavailability (F) after i.m. administration of cefepime was 86.8 +/- 7.5%. The extent of plasma protein binding measured in vitro was 14.8 +/- 0.54%. The drug was detected in urine for 36 h postadministration by both routes.
引用
收藏
页码:499 / 503
页数:5
相关论文
共 27 条
[1]  
Baggot J. D., 1978, Journal of Veterinary Pharmacology and Therapeutics, V1, P5, DOI 10.1111/j.1365-2885.1978.tb00300.x
[2]   HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC ANALYSIS OF BMY-28142 IN PLASMA AND URINE [J].
BARBHAIYA, RH ;
FORGUE, ST ;
SHYU, WC ;
PAPP, EA ;
PITTMAN, KA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (01) :55-59
[3]   PHARMACOKINETICS OF CEFEPIME AFTER SINGLE AND MULTIPLE INTRAVENOUS ADMINISTRATIONS IN HEALTHY-SUBJECTS [J].
BARBHAIYA, RH ;
FORGUE, ST ;
GLEASON, CR ;
KNUPP, CA ;
PITTMAN, KA ;
WEIDLER, DJ ;
MOVAHHED, H ;
TENNEY, J ;
MARTIN, RR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (03) :552-557
[4]   SAFETY, TOLERANCE, AND PHARMACOKINETICS OF CEFEPIME ADMINISTERED INTRAMUSCULARLY TO HEALTHY-SUBJECTS [J].
BARBHAIYA, RH ;
KNUPP, CA ;
TENNEY, J ;
MARTIN, RR ;
WEIDLER, DJ ;
PITTMAN, KA .
JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (10) :900-910
[5]  
BARBHAIYA RH, 1991, DRUG METAB DISPOS, V19, P68
[6]  
CARRELTS JC, 1999, ANN PHARMACOTHER, V33, P1258
[7]   PHARMACOKINETICS OF THE NOVEL CEPHALOSPORIN CEFEPIME (BMY-28142) IN RATS AND MONKEYS [J].
FORGUE, ST ;
SHYU, WC ;
GLEASON, CR ;
PITTMAN, KA ;
BARBHAIYA, RH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (05) :799-804
[8]   Comparison of cefepime pharmacokinetics in neonatal foals and adult dogs [J].
Gardner, SY ;
Papich, MG .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2001, 24 (03) :187-192
[9]  
Gibaldi M., 1982, PHARMACOKINETICS, P409
[10]  
Guglick MA, 1998, AM J VET RES, V59, P458